# Frequency-Dependent Premature Differentiation of Pheochromocytoma Cells Exhibits Band-Pass Filter Behavior Correlation with Intracellular Enzyme Activation Kinetics

**Authors:** Zubaidah Ningsih, Nguyen H. N. Tran, Andrew H. A. Clayton

PMC · DOI: 10.3390/ijms26115287 · 2025-05-30

## TL;DR

This study shows how pheochromocytoma cells differentiate in response to periodic growth factor inputs, with enzyme activation patterns influencing the outcome.

## Contribution

The novel contribution is linking input frequency to enzyme activation kinetics using a model that predicts differentiation outcomes.

## Key findings

- Differentiation peaks at specific input frequencies for EGF and NGF.
- A model combining enzyme activation transfer functions qualitatively matches experimental results.
- The system exhibits band-pass filter behavior in response to input frequency.

## Abstract

Advances in microfluidics, optogenetics and electronics have enabled the study of dynamically controlled inputs on cellular fate. Here, we applied a microfluidic system to deliver periodic inputs of growth factors to pheochromocytoma cells and measured the extent of premature differentiation as a function of input frequency. Epidermal growth factor-triggered differentiation peaked at two cycles/hour, while nerve growth factor-triggered differentiation peaked at one cycle/hour. To interpret the results, we analyzed a published model that attributed pheochromocytoma cell differentiation to the linear combination of activated enzymes extracellular signal-regulated kinase (ERK), cAMP response element binding protein (CREB), protein kinase B (AKT) and c-Jun N-terminal kinase (JNK) at specific times after step input stimulation. Transfer functions for enzyme activation were derived from the published time-domain activation kinetics and these transfer functions were combined in a parallel architecture as a predictor of neurite outgrowth, as a function of input frequency. Qualitative agreement was observed between the model and the experiments.

## Linked entities

- **Proteins:** EPHB2 (EPH receptor B2), CREB1 (cAMP responsive element binding protein 1), AKT1 (AKT serine/threonine kinase 1), MAPK8 (mitogen-activated protein kinase 8)
- **Chemicals:** epidermal growth factor (PubChem CID 56841751)

## Full-text entities

- **Genes:** NGF (nerve growth factor) [NCBI Gene 4803] {aka Beta-NGF, HSAN5, NGFB}, MAPK1 (mitogen-activated protein kinase 1) [NCBI Gene 5594] {aka ERK, ERK-2, ERK2, ERT1, MAPK2, NS13}, PTK2B (protein tyrosine kinase 2 beta) [NCBI Gene 2185] {aka CADTK, CAKB, FADK2, FAK2, PKB, PTK}, EGF (epidermal growth factor) [NCBI Gene 1950] {aka HOMG4, URG}, CREB1 (cAMP responsive element binding protein 1) [NCBI Gene 1385] {aka CREB, CREB-1}, MAPK8 (mitogen-activated protein kinase 8) [NCBI Gene 5599] {aka JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}
- **Diseases:** Pheochromocytoma (MESH:D010673)

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12155341/full.md

---
Source: https://tomesphere.com/paper/PMC12155341